Company
Sofinnova Investments
Investments
| Company | Round | Date | Lead |
|---|---|---|---|
| Expedition Therapeutics | Series B | 2026-08-05 | |
| Claris Biotherapeutics, Inc. | Series B | 2026-08-03 | |
| City Therapeutics, Inc. | Series B | 2026-06-09 | Lead |
| Aeovian Pharmaceuticals | Funding | 2025-12-16 | |
| Expedition Therapeutics | Series A | 2025-10-10 | Lead |
| Avenzo Therapeutics | Series B | 2025-09-22 | |
| ARTBIO | Series B | 2025-07-29 | Lead |
| Atsena Therapeutics | Series C | 2025-04-04 | |
| Axonis Therapeutics | Series A Funding | 2024-10-30 | |
| Marea Therapeutics | Funding | 2024-06-19 | Lead |
| Aeovian Pharmaceuticals | Financing | 2024-03-29 | |
| Avenzo Therapeutics | Series A1- Financing | 2024-03-27 | Lead |
| Capstan Therapeutics | Series B Financing | 2024-03-21 | |
| BioAge Labs | Series D | 2024-02-13 | Lead |
| Star Therapeutics | Series C Funding | 2023-09-05 | Lead |
| Rapport Therapeutics | Series B Funding | 2023-08-23 | Lead |
| ArriVent Biopharma | Series B Financing | 2023-03-27 | Lead |